𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunology of Inflammatory Bowel Disease and Molecular Targets for Biologics

✍ Scribed by Dave, Maneesh; Papadakis, Konstantinos A.; Faubion, William A.

Book ID
125833395
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
874 KB
Volume
43
Category
Article
ISSN
0889-8553

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic drug monitoring of biologics
Therapeutic drug monitoring of biologics for inflammatory bowel disease
✍ Jean-FrΓ©dΓ©ric Colombel; Brian G. Feagan; William J. Sandborn; Gert Van Assche; A πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 434 KB πŸ‘ 1 views

## Background: Although tumor necrosis factor (tnf) antagonists are effective for the treatment of crohn's disease and ulcerative colitis, lack and loss of clinical response is a clinical challenge. accordingly, the use of therapeutic drug monitoring has been proposed as a means to optimize treatme

Vaccination strategies for patients with
Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
✍ Gil Y. Melmed πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

The treatment of Crohn's disease and ulcerative colitis frequently includes potent immunomodulator and biologic therapy to reduce intestinal inflammation, heal fistulae, limit complications, and improve quality of life. These medications may increase susceptibility to and severity of infections, man